Author

Laura Tovar-Martinez

Institute of Advanced Chemistry of Catalonia

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Alberto Guillermo Arias· 1 shared Aman P. ManniD· 1 shared Cristian Roberto SmulskiiD· 1 shared Eliana K. AsciuttoiD· 1 shared Erkki RuoslahtiiD· 1 shared Kristina Põšnograjeva· 1 shared Lorena Simón‐GraciaiD· 1 shared Maarja HaugasiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alberto Guillermo Arias

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A CYCLIC PEPTIDE TARGETS GLIOBLASTOMA BY BINDING TO ABERRANTLY EXPOSED SNAP25

Alberto Guillermo Arias, Laura Tovar-Martinez, Eliana K. Asciutto, Aman P. Mann, Kristina Põšnograjeva, Lorena Simón‐Gracia, Míriam Royo, Maarja Haugas, Tambet Teesalu, Cristian Roberto Smulski, Erkki Ruoslahti, Pablo Scodeller

This paper identifies a cyclic peptide, CES, that targets glioblastoma by binding to aberrantly exposed SNAP25, showing its potential as a drug delivery tool and molecular marker.

Molecular Pharmaceutics · Nov 22, 2024Peer-reviewedCancer Biology